Skip to main content
. 2014 Feb 17;8(3):717–727. doi: 10.1016/j.molonc.2014.02.002

Table 1.

Patient clinical and pathological characteristics and details of sample collection.a

Patient ID Age at diagnosis, y Histology at diagnosis ER status PR status HER2 status Pathological lymph node status Tumor size, cm Histological grade AJCC stageb
MD40 78 IDC N N N P 2.8 3 IIB
MD49 52 IDC, ILC P P N P 2.8 2 IIB
MD50 47 IDC P P N P 2.3 2 IIB
MD52 49 IDC P P N N 2.3 2 IIA
MD53 57 IDC N N N N 3 3 IIA
MD57 64 ILC P P N N 4.6 2 IIA
MD64 82 IDC N N P N 2.8 3 IIA
MD66 57 IDC P P N N 2.6 2 IIA
MD67 44 IDC, ILC P P N P 3 2 IIB
MD69 60 IDC, ILC P P N N 2.9 2 IIA
MD71 48 IDC P P N P 2.9 3 IIB
a

IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; N = negative; P = positive.

b

AJCC Stage = American Joint Committee on Cancer staging classification, 6th edition (Fleige and Pfaffl, 2006).